key: cord-0761045-ojdcag0r
authors: Aranda-Abreu, Gonzalo Emiliano
title: Response to: Amantadine, COVID-19 and Parkinsonism
date: 2020-07-20
journal: Arch Med Res
DOI: 10.1016/j.arcmed.2020.07.002
sha: 25c010bda0dd4f0e74edde37105e4204f75ccba7
doc_id: 761045
cord_uid: ojdcag0r

nan

The fact that Parkinson's patients get COVID-19 is probably because their main medication was Levodopa and not amantadine.

I would like to point out that amantadine is an antiviral that is able to mitigate the effects of COVID-

Phenomenology and outcomes of in-patients with

Parkinson's disease during COVID-19 pandemic

Online ahead of print

Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study

Amantadine as a drug to mitigate the effects of COVID-19

Amantadine Treatment for People with COVID-19

Use of amantadine in a patient with SARS-CoV-2

Online ahead of print